欢迎来到OAJRC平台!

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Internal Medicine. 2021; 2: (1) ; 44-46 ; DOI: 10.12208/j. ijim.20210013.

Treatment and experience of mild infection with novel coronavirus
新型冠状病毒轻症感染的治疗与体会

作者: 翁志华*,

扬州市第二人民医院 江苏扬州

*通讯作者: 翁志华,单位:扬州市第二人民医院 江苏扬州;

发布时间: 2021-03-16 总浏览量: 40

摘要

目的 探究分析舒肝颗粒+小剂量阿普唑仑结合中药清肺排毒汤+开天门疗法对新型新型冠状病毒轻症感染的治疗。方法 选取于2020年12月1日至2020年12月31日到我院接受新型冠状病毒轻症感染治疗的患者共320例,作为本次研究对象。按照电脑盲选的方式,将320例新型冠状病毒轻症感染的患者随机分为对照组与观察组。其中对照组采用舒肝颗粒+小剂量阿普唑仑的治疗模式进行干预;观察组采用在对照组的基础上结合中药清肺排毒汤+开天门疗法的治疗方式进行干预。对比分析对照组与观察组的治疗有效率、睡眠与焦虑情况。结果 对照组与观察组经治疗干预后,对比两组治疗有效率、睡眠与焦虑情况、康复时间发现,观察组明显优于对照组,其中P<0.05,差异具有统计学意义。结论 采用舒肝颗粒+小剂量阿普唑仑结合中药清肺排毒汤+开天门的治疗措施能够在一定程度上提升治疗有效率,改善患者睡眠与焦虑情况,在临床应用中具有良好的效果。

关键词: 新型冠状病毒;舒肝颗粒;小剂量阿普唑仑;清肺排毒汤;开天门疗法

Abstract

Objective To explore and analyze interferon α Injection combined with Qingfei Paidu Decoction + kaitianmen therapy in the treatment of mild infection of new novel coronavirus.
Methods a total of 320 patients with mild novel coronavirus infection in our hospital from August 2021 to September 2021 were selected as the subjects of this study. According to the method of computer blind selection, 320 patients with mild novel coronavirus infection were randomly divided into control group and observation group. The control group was treated with interferon α The treatment mode of injection was used for intervention; The observation group was intervened on the basis of the control group combined with Qingfei Paidu Decoction + kaitianmen therapy. The treatment efficiency, sleep and anxiety of the control group and the observation group were compared and analyzed.
Results after treatment intervention, the effective rate, sleep and anxiety of the two groups were compared. It was found that the observation group was significantly better than the control group (P < 0.05).
Conclusion   interferon α The treatment measures of injection combined with Qingfei Paidu Decoction + kaitianmen can improve the treatment efficiency to a certain extent, improve patients' sleep and anxiety, and have a good effect in clinical application.

Key words: Novel coronavirus; α Injection; Qingfei Paidu Decoction; Tianmen therapy

参考文献 References

[1] 罗丹,王霆,谭忠元,郭珊,余志,刘艳,张源,王宝香,高源,王汉中,梅红,郑振华.新型冠状病毒——从基础研究到临床[J].中国科学:生命科学,2021,51(11):1508-1522.

[2] 罗玲,方章兰,田艺,潘玲,兰霞.2019新型冠状病毒(2019-nCoV)肺炎治疗药物评价[J].临床肺科杂志,2020,25(11):1749-1753.

[3] 贾秀玲,李棒棒,孙忠华,赵杉杉,冷萍.新型冠状病毒感染及新型冠状病毒肺炎治疗药物研究进展[J].山东医药,2020,60(09):108-112.

[4] 靳英辉,蔡林,程真顺,武汉大学中南医院新型冠状病毒感染的肺炎防治课题组.新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(完整版)[J].医学新知,2020,30(01):35-64.

[5] 程琦,高杉,于春泉.新型冠状病毒肺炎的中西医防治研究进展[J].天津中医药,2020,37(06):627-633.

[6] 范文瀚,梁雪松,陈怡,陈志辉.干扰素α注射对新型冠状病毒感染轻症或无症状者病毒核酸转阴的疗效初探[J].药学服务与研究,2021,21(05):392-395.

引用本文

翁志华, 新型冠状病毒轻症感染的治疗与体会[J]. 国际内科前沿杂志, 2021; 2: (1) : 44-46.